Visivra Official Website › Sources and review
MethodSources and Review: How Govisivra Checks Each Visivra Page
Visivra Team at Govisivra · physician review: Dr. Preston Sullivan, MD · last revised
Every Visivra fact on this website has a named source, and every page is checked by a physician.
Govisivra reads the artwork first, the seller second and the published research third, quotes trials only for what they tested, and sends each page to Dr. Preston Sullivan, MD for medical review. A reader who finds an error gets it fixed on the page, with a new revision date.
The source ladder, the review, and the correction route, set out so that any page can be checked against them.
Govisivra and the Visivra pages: who is responsible
Govisivra is the licensed U.S. retail desk for Visivra. It works from 60 Wall Street in New York, receives returns at 205 Hudson Street, and sells through the seller’s own checkout. It is a retailer: it does not formulate, manufacture or test the capsules, and it does not own the brand.
Every page is written by the Visivra Team at Govisivra. The team reads the eighteen product files that came with the stock, the seller’s page, and each record it cites, and it signs every page so that a reader knows whom to hold to account.
Every page is reviewed for medical accuracy by Dr. Preston Sullivan, MD, a physician. The reviewer’s name appears under each page title and in the page ledger at the foot of the page, and the about page explains the role.
The Visivra source ladder
Sources are ranked. When two of them disagree, the higher one wins and the page records the disagreement instead of smoothing it over.
- The artwork. The front panel shows the name, 30 Capsules, Dietary Supplement and an eye glyph, and the ingredient tile names six actives. What the artwork prints is quoted, not paraphrased, and a bottle in a reader’s hand outranks this website.
- The seller’s page and this desk’s batch paperwork. The three packs at $158, $207 and $294, the shipping, the 60-day guarantee, lot VIS-26/GO-1787 and its certificate reference, each printed with the date it was read.
- Public health agencies. The National Eye Institute, MedlinePlus, NIDDK and the NIH Office of Dietary Supplements for eye conditions and nutrients; the FDA for what a supplement label may say.
- Published trials, each opened at its PubMed record. They describe what an ingredient did at a stated amount in a stated group; they are never offered as evidence about the finished Visivra capsule, which has not been tested in a published trial.
Reading a Visivra trial: what gets quoted and what does not
Three facts are taken from every trial a page cites: the amount given, the people who took it, and how long the trial ran. Those three are what let a reader judge whether a result could apply to them, so they travel together or not at all.
Some things are deliberately left out. A finding in people with a diagnosis is not presented as a benefit for healthy eyes. A study in children is not presented as evidence for adults. And a popular story that did not survive placebo control, such as bilberry improving night vision, is not repeated because it would be easy to sell.
Forty-one sources are cited across the site. Each link opens the record itself, so that any reader can check the figure against the paper.
What the physician checks on a Visivra page
The review covers the product pages, the reading of the artwork, the ingredient, side-effect and interaction pages, and the journal. For each page it confirms three things: the wording matches the artwork and the cited sources; the safety notes are complete for a general reader; and nothing promises more than the four statements printed on the pack.
It does not make Visivra a product recommended by Dr. Preston Sullivan, MD, it does not predict what your own eyes will do, and it does not replace advice from a clinician who has examined you. Reader questions go to the website desk, not to the reviewer.
A page is reviewed again before its revision date changes whenever the artwork, a price, the guarantee or a safety source changes.
Visivra claims: the four the pack prints, and nothing beyond
The pack makes four statements: support visual clarity, promote healthy retinal function, maintain long-term eye wellness, and help defend the eyes from blue light exposure. They mark the outer edge of what any page here says Visivra is for.
- No page says Visivra treats, slows or prevents macular degeneration, cataract, glaucoma or diabetic eye disease.
- No page treats Visivra as the AREDS2 formula, which was tested at stated amounts in people who already had macular degeneration.
- No page reads the doctor-formulated mark as a named doctor’s endorsement; the mark names nobody.
- No page treats an FDA-registered facility mark as approval, because the FDA does not approve supplements before sale, as its questions and answers on dietary supplements explain.
When a Visivra page sends you to an eye doctor
Some situations are never presented as a reason to try a supplement. Every page that touches use or safety points them to a clinician instead.
- Sudden vision loss, a burst of floaters, flashes or a shadow over the view: same-day care, citing the National Eye Institute on retinal detachment.
- A painful, red or light-sensitive eye: a prompt examination.
- Diabetes: a dilated eye exam at least once a year, citing NIDDK on diabetic eye disease.
- Glaucoma or a family history of it: regular checks and any prescribed drops first, citing the NEI glaucoma page.
- Smoking, or another product with zinc or vitamin A: a question to settle with the order desk and a pharmacist before the first capsule.
Visivra figures we calculate, and figures we only report
Reported figures are copied with their owner named: a trial’s dose, the seller’s price, the guarantee length, the review summary supplied with this desk’s product pack. Calculated figures are this desk’s own arithmetic and the working is shown, such as $294 for six bottles coming to $49 a bottle and $1.63 a day at one capsule.
No figure is invented to fill a gap. The artwork gives no amount for any of the six actives, so no page states one. When a checkout price differs from a page, the checkout is right and the page is corrected.
Visivra ratings and order counts on Govisivra
The 4.4 average, the 683 written reviews and the 6,554 orders come from the review summary supplied with this desk’s product pack. The desk has not verified them against individual orders, so every page that shows them says what they are, and the three-star and four-star lines are printed beside the five-star ones.
The editorial score on the home page is the desk’s own judgement, with the reasoning for each row, and it is labelled that way rather than mixed with customer ratings.
How Govisivra is paid when you order Visivra
Govisivra earns money when a reader orders through the buttons on this website. Those links are marked as sponsored and lead to the seller’s checkout, where the price is the checkout’s own.
The rules on this page are what stop that payment from shaping the pages. The unpublished amounts, the mark that names nobody and the doctor-first advice all stay on the site whether or not they help an order.
Visivra corrections: how a page is fixed and re-dated
Each page carries its last revision date under the title and in the page ledger, and the same date is in its structured data. That date changes only when something on the page does.
To report an error, use the contact page or the website inbox in the footer, naming the page and the sentence. If it is a factual error the desk fixes it on the page and says so; if it is a difference of interpretation, the reply says that instead. A sentence that was wrong is corrected in place rather than quietly deleted.
Anything about an order, a parcel or a refund belongs to the order desk, as the refund policy explains; the website inbox cannot see orders.
Visivra sources and review: questions readers ask
Does the physician recommend Visivra?
No. The physician review checks that a page is accurate and that its safety notes are adequate. It is not a recommendation to buy or take the product.
Is Govisivra the maker of Visivra?
No. Govisivra is the licensed U.S. retail desk for Visivra. It sells the product and writes this website; the formula belongs to the maker.
Where do the rating and order numbers come from?
From the review summary supplied with this desk's product pack. They have not been verified against individual orders, and pages say so.
Why are trial doses printed beside the ingredients?
Because the artwork prints no amounts. A trial dose shows what a study actually gave people, and each is credited to its trial.
What happens after I report a mistake?
The desk checks it against the artwork or the source. If the page is wrong, it is corrected where the error is and the revision date moves.
Does being paid on orders change the pages?
The rules on this page exist so that it does not. Material that does not help a sale, such as the unpublished amounts and the doctor-first advice, stays published.
